Target intelligence / Profile preview

LRRC59 antisense RNA 1 (LRRC59-AS1)

Target
LRRC59-AS1
Molecular classification
Other (Antisense long non-coding RNA)
01

Overview

LRRC59 antisense RNA 1 (LRRC59-AS1) is presumed to be a long non-coding RNA transcribed in the antisense direction from the LRRC59 gene locus. Antisense lncRNAs are a diverse class of transcripts often involved in regulating expression of their sense gene partners through epigenetic, transcriptional, or post-transcriptional mechanisms. While many antisense lncRNAs impact cancer biology and cellular processes by modulating their sense gene, there is currently no direct evidence or published studies specifically detailing the function, disease role, or druggability of LRRC59-AS1. Most research focuses on LRRC59 protein, which is an ER membrane protein involved in RNA binding, translation regulation, and cancer prognosis[1][3][5].

02

Biological functions

Potential regulatory functions (e.g., modulation of LRRC59 gene expression via RNA-RNA interactions, recruitment of chromatin modifiers, or acting as competing endogenous RNA), but specific data for LRRC59-AS1 is lacking
03

Disease associations

Other (Potential involvement in cancer or cellular regulation by analogy to other antisense lncRNAs; direct evidence for LRRC59-AS1 in disease is absent)

Beyond the preview

Go deeper on LRRC59 antisense RNA 1 (LRRC59-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on LRRC59 antisense RNA 1 (LRRC59-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call